Comparisons of high-risk cervical HPV infections in Caribbean and US populations

Infectious Agents and Cancer

Volumn 4, Issue SUPPL. 1, 2009, Pages

  Ragin, Camille C ^a,b,f   Watt, Angela ^c   Markovic, Nina ^a   Bunker, Clareann H ^a,e   Edwards, Robert P ^b   Eckstein, Stacy ^a,b   Fletcher, Horace ^c   Garwood, David ^c   Gollin, Susanne M ^b   Jackson, Maria ^c   Patrick, Alan L ^a,e   Smikle, M ^c   Taioli, Emanuela ^a,b,f   Wheeler, Victor W ^a,d,e   Wilson, Jacque B ^d   Younger, N ^c   McFarlane Anderson, Norma ^c  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c UNIVERSITY OF THE WEST INDIES   (Jamaica)

^d Trinidad and Tobago Cancer Society   (Trinidad and Tobago)

^e Tobago Health Studies Office   (Trinidad and Tobago)

^f SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; CAUCASIAN; CENTRAL AMERICA; CONDYLOMA ACUMINATUM; CONFERENCE PAPER; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN EXPERIMENT; INFECTION RISK; JAMAICA; PREVALENCE; UNITED STATES; WART VIRUS;

EID: 60349087416     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-4-S1-S9     Document Type: Conference Paper

References (24)

1. LAG Ries D Melbert M Krapcho A Mariotto BA Miller EJ Feuer, SEER Cancer Statistics Review, 1975-2004 National Cancer Institute. Bethesda, MD 2007
2. GLOBOCAN 2002 Cancer Incidence, Mortality and Prevalence Worldwide IARC CancerBase, Version 2.0 No. 5. J Ferlay F Bray P Pisani DM Parkin, Lyon, IARC Press 2004
3. HPV-mediated transformation of the anogenital tract. RD Steenbergen J de Wilde SM Wilting AA Brink PJ Snijders CJ Meijer, J Clin Virol 2005 32 Suppl 1 S25 S33 10.1016/j.jcv.2004.11.019 15753009
4. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. AR Kreimer GM Clifford P Boyle S Franceschi, Cancer Epidemiol Biomarkers Prev 2005 14 467 475 10.1158/1055-9965.EPI-04-0551 15734974
5. Prevalence of cancer-associated viruses in the Caribbean islands. CC Ragin J Kuo E Taioli, Cancer Investigation 2008 19034776
6. Distinct distribution of HPV types among cancer-free Afro-Caribbean women from Tobago. CCR Ragin VW Wheeler JB Wilson CH Bunker AL Patrick SM Gollin, Biomarkers 2007 12 510 522 10.1080/13547500701340384 17701749
7. High-risk and multiple human papillomavirus (HPV) infections in cancer-free Jamaican women. A Watt D Garwood M Jackson N Younger C Ragin M Smikle, Infectious Agents and Cancer
8. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Munoz FX Bosch S de Sanjose R Herrero X Castellsague KV Shah, N Engl J Med 2003 348 518 527 10.1056/NEJMoa021641 12571259
9. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. GM Clifford S Gallus R Herrero N Munoz PJ Snijders S Vaccarella, Lancet 2005 366 991 998 10.1016/S0140-6736(05)67069-9 16168781
10. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. N Munoz FX Bosch X Castellsague M Diaz S de Sanjose D Hammouda, Int J Cancer 2004 111 278 285 10.1002/ijc.20244 15197783
11. FDA Licenses New Vaccine for Prevention of Cervical Cancer and Other Diseases in Females Caused by Human Papillomavirus, Food & Drug Administration. http://www.fda.gov/bbs/topics/NEWS/2006/NEW01385.html
12. Poverty eradication and decreased human papilloma virus related cancer of the penis and vulva in Jamaica. HM Fletcher B Hanchard, J Obstet Gynaecol 2008 28 333 335 10.1080/01443610802044981 18569481
13. Sociodemographic Factors Associated With High-Risk Human Papillomavirus Infection. JA Kahn D Lan RS Kahn, Obstet Gynecol 2007 110 87 95 17601901
14. Social differences in sexual behaviour and cervical cancer. S de Sanjose FX Bosch N Munoz K Shah, IARC Sci Publ 1997 309 317 9353671
15. Cervical dysplasia and cancer and the use of hormonal contraceptives in Jamaican women. N McFarlane-Anderson PE Bazuaye MD Jackson M Smikle HM Fletcher, BMC Womens Health 2008 8 9 18513406 10.1186/1472-6874-8-9
16. Lifestyle and cervical dysplasia in Jamaica. PE Bazuaye H Fletcher N McFarlane-Anderson, Int J Gynaecol Obstet 2004 84 175 177 10.1016/S0020-7292(03) 00315-1 14871525
17. Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark. SK Kjaer G Breugelmans C Munk J Junge M Watson T Iftner, Int J Cancer 2008 123 1864 1870 10.1002/ijc.23712 18661520
18. HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial. HC Kitchener M Almonte P Wheeler M Desai C Gilham A Bailey, Br J Cancer 2006 95 56 61 10.1038/sj.bjc.6603210 16773068
19. Prevalence of HPV infection among females in the United States. EF Dunne ER Unger M Sternberg G McQuillan DC Swan SS Patel, JAMA 2007 297 813 819 10.1001/jama.297.8.813 17327523
20. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. R Herrero PE Castle M Schiffman MC Bratti A Hildesheim J Morales, J Infect Dis 2005 191 1796 1807 10.1086/428850 15871111
21. Pennsylvania Department of Health Annual Report of Vital Statistics, Pennsylvania Vital Statistics 2006. http://www.dsf.health.state.pa.us/health/ cwp/view.asp?a=175&q=250106
22. U.S.Census Bureau, Population Division/International Programs Center, International Database Summary Demographic Data. http://www.census.gov/ipc/www/ idb/
23. National Institutes of Health, National Institutes of Health, National Center for Research Resources. http://www.ncrr.nih.gov/
24. NIH Roadmap for Medical Research, NIH Roadmap for Medical Research, Re-engineering the Clinical Research Enterprise. http://nihroadmap.nih.gov/ clinicalresearch/overview-translational.asp